Home/Filings/4/0000899243-19-013034
4//SEC Filing

Farrell Edward 4

Accession 0000899243-19-013034

CIK 0001596946other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:05 PM ET

Size

16.8 KB

Accession

0000899243-19-013034

Insider Transaction Report

Form 4
Period: 2019-05-08
Transactions
  • Sale

    Common Stock

    2019-05-08$8.67/sh22,500$195,0752,133 total
Holdings
  • Options to acquire ordinary shares

    Exp: 2023-04-10Ordinary Shares (96,000 underlying)
    96,000
  • Employee Stock Option (right to buy)

    Exercise: $7.58Exp: 2027-05-23Ordinary Shares (40,000 underlying)
    40,000
  • Restricted Stock Units

    Ordinary Shares (11,175 underlying)
    11,175
  • Employee Stock Option (right to buy)

    Exercise: $11.92Exp: 2026-05-31Ordinary Shares (30,000 underlying)
    30,000
  • Employee Stock Option (right to buy)

    Exercise: $15.17Exp: 2025-05-19Ordinary Shares (30,000 underlying)
    30,000
  • Employee Stock Option (right to buy)

    Exercise: $8.00Exp: 2024-04-29Ordinary Shares (79,000 underlying)
    79,000
  • Multi-year Performance Based Restricted Stock Unit

    Exp: 2019-12-31Ordinary Shares (50,000 underlying)
    50,000
  • Restricted Stock Units

    Ordinary Shares (36,773 underlying)
    36,773
Footnotes (12)
  • [F1]20,000 options have vested and remain exercisable and 10,000 options will vest on June 1, 2019.
  • [F10]On May 23, 2018, the Reporting Person was granted 11,175 restricted stock units that would vest on May 24, 2019 if certain business milestones were achieved on or before December 31, 2018. The business milestones were reached on December 12, 2018, and accordingly the restricted stock units will vest on May 24, 2019.
  • [F11]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2018.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.85, inclusive. The Reporting Person undertakes to provide to Quotient Limited and any security holder of Quotient Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (12) to this Form 4.
  • [F2]All 30,000 options have vested and remain exercisable.
  • [F3]The exercise price will be paid in pounds sterling, at GBP0.003 per share.
  • [F4]All 96,000 options have vested and remain exercisable.
  • [F5]All 79,000 options have vested and remain exercisable.
  • [F6]13,333 vested on May 24, 2018 and remain exercisable, 13,333 options will vest on May 24, 2019, 13,334 options will vest on May 24, 2020.
  • [F7]Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $22.00 per share for 20 consecutive trading days during the period April 1, 2019 to December 31, 2019.
  • [F8]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F9]On May 24, 2018, the Reporting Person was granted 36,773 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2019.

Issuer

Quotient Ltd

CIK 0001596946

Entity typeother

Related Parties

1
  • filerCIK 0001604629

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:05 PM ET
Size
16.8 KB